Physician profile
Andreas Barth
NPI 1689992190
$19,251.51
in general payments reported to CMS, 2019-2025
10 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,931 · 2022: $6,045 · 2023: $170 · 2024: $4,559 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,005 · Food and Beverage: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,004.87 |
| Food and Beverage | $2,270.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,176.11 | 2021-2024 | Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Ns Pharma, INC. | $7,100.00 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $2,784.00 | 2021 | |
| Altathera Pharmaceuticals LLC | $1,167.33 | 2021 | |
| Biosense Webster, INC. | $448.59 | 2022-2025 | Carto 3, Smartablate |
| Abbott Laboratories | $325.92 | 2025 | Aveir |
| Boston Scientific Corporation | $199.31 | 2024-2025 | Farapulse, Rhythmia Mapping System, Emblem Mri S-Icd |
| Cardiva Medical, INC. | $26.98 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Bayer Healthcare Pharmaceuticals INC. | $23.27 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Barth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.